Mark Hopman

Mark Hopman

Corporate Officer/Principal en BETA BIONICS, INC. .

Fortuna: 2 M $ al 31/05/2026

48 años
Health Technology
Consumer Services
Technology Services

Perfil

Mr. Mark Hopman is a Chief Commercial Officer at Beta Bionics, Inc. Mr. Hopman was previously employed as a Vice President-Market Access by Pear Therapeutics (US), Inc. and a Director-Retail Distribution by DexCom, Inc. He received his undergraduate degree from The Ohio State University College of Pharmacy and an MBA from Williams College of Business.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
24/06/2026 129.354 ( 0,29 % ) 2 M $ 31/05/2026
29/01/2025 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Mark Hopman

EmpresasCargoInicio
BETA BIONICS, INC. Corporate Officer/Principal 01/03/2023

Antiguos cargos conocidos de Mark Hopman.

EmpresasCargoFin
Corporate Officer/Principal 01/03/2023
DEXCOM, INC. Corporate Officer/Principal 01/06/2021
Ver el detalle de la experiencia de Mark Hopman.

Formación de Mark Hopman.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

18

Relaciones de 1er grado

5

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas5

Health Technology

Consumer Services

Technology Services

Consumer Services

Health Technology